The Next Battleground in Orthopedics May Be the Shoulder
Shoulder arthroplasty is expanding. Rotator cuff repair is becoming a platform for biologic innovation. Arthroscopy is treating increasingly complex pathology.
The clinical momentum is clear. The commercial question is where it is happening.
Arthroplasty Is Expanding
Reverse replacement is competing in broader patient populations.
Repair Is Evolving
Biologic augmentation is targeting tendon healing and retear risk.
Identified Procedures
Across 16,277 physicians and 5,157 facilities.
Leadership Is Concentrated
The top 100 facilities account for nearly one-fifth of activity.
The shoulder is no longer a quiet corner of orthopedics. Several of its largest procedure categories are changing at the same time.
The Shoulder Market Is Moving
In shoulder arthroplasty, a 2025 meta-analysis of 4,819 cases found that reverse total shoulder arthroplasty produced comparable clinical outcomes and a lower revision rate than anatomic replacement in patients with rotator cuff-intact osteoarthritis—although anatomic replacement retained an advantage in external rotation.
Rotator cuff repair is moving beyond stronger fixation toward technologies intended to improve healing. Recent systematic reviews found promising results for bioinductive collagen implants, while also emphasizing that better comparative evidence is still needed.
Arthroscopy is advancing as well. A 2024 systematic review of 2,307 shoulders found high patient satisfaction, low recurrent instability and strong return-to-play rates following arthroscopic stabilization for posterior shoulder instability.
This is not one procedure growing. It is an entire shoulder category becoming more competitive.
The Literature Explains Why. It Doesn’t Explain Where.
Clinical research shows how shoulder surgery is changing. Commercial teams need to know who is driving that change.
Which physicians are performing the most shoulder procedures? Which facilities have become regional centers of activity? And is leadership concentrated—or widely distributed?
Looking Beyond the Literature
ClearSight Health analyzed more than 2.2 million identified U.S. procedures across shoulder arthroplasty, shoulder arthroscopy and rotator cuff procedure groups, involving 16,277 physicians and 5,157 facilities. Data is refreshed through Q2 2026.
Shoulder Activity Is Concentrated
The market is broad, but its highest levels of activity are not evenly distributed.
Top 20 facilities account for more than 6% of all identified procedures.
Top 100 facilities account for nearly 20% while representing less than 2% of facilities in the analysis.
Among the highest-volume facilities are:
| Facility | City, State |
|---|---|
| Strong Memorial Hospital | Rochester, NY |
| The Surgery Center of Huntsville | Huntsville, AL |
| Orthopaedic Surgery Center of Panther Creek | Cary, NC |
| Orthopedic One Surgery Center at Easton | Columbus, OH |
| Miami Surgical Center | Miami, FL |
| Surgical Center of Greensboro | Greensboro, NC |
| Piedmont Hospital | Atlanta, GA |
| NYU Langone Hospitals | New York, NY |
| OrthoIndy Hospital | Brownsburg, IN |
| Nebraska Orthopaedic Hospital | Omaha, NE |
Facility names open the corresponding ClearSight platform profile in a new tab.
The Physicians Leading the Market
The physician landscape is more distributed than the facility landscape, but a clear group of high-activity physicians still emerges.
| Physician | City, State |
|---|---|
| Peter Simonian, MD | Clovis, CA |
| Wesley Dosher, MD | Conway, SC |
| Paul Re, MD | Concord, MA |
| Jessica Aronowitz, MD | Bangor, ME |
| Kevin Bonner, MD | Norfolk, VA |
| Ilya Voloshin, MD | Rochester, NY |
| Michael Shin, MD | Elizabeth City, NC |
| Peter Tomasello, MD | Bayside, NY |
| Marston Holt, MD | Webster, TX |
Physician names open the corresponding ClearSight platform profile in a new tab.
The Real Shoulder Race
The race is not simply to build the next shoulder technology.
It is to identify the physicians and facilities that will define the next decade of shoulder surgery before everyone else does.
Clinical studies explain why the shoulder market is moving. Real-world commercial intelligence shows where that momentum is concentrated—and where the next opportunity may emerge.
References
- Thamrongskulsiri N, et al. Comparison of Revision Rates and Clinical Outcomes between Anatomic and Reverse Total Shoulder Arthroplasty for Rotator Cuff-Intact Osteoarthritis: A Systematic Review and Meta-Analysis. Clin Orthop Surg. 2025. View source
- Hurley ET, et al. Bioinductive Collagen Implant Has Potential to Improve Rotator Cuff Healing: A Systematic Review. Arthroscopy. 2025. View source
- Warren JR, et al. Bioinductive Patch as an Augmentation for Rotator Cuff Repair: A Systematic Review and Meta-Analysis. J Shoulder Elbow Surg. 2024. View source
- Ralph JE, et al. Outcomes of Arthroscopic Stabilization for Posterior Shoulder Instability: A Systematic Review. J Shoulder Elbow Surg. 2024. View source
- ClearSight Health. Analysis of more than 2.2 million identified U.S. procedures across shoulder arthroplasty, shoulder arthroscopy and rotator cuff procedure groups, involving 16,277 physicians and 5,157 facilities. Internal commercial intelligence platform. Data refreshed through Q2 2026.
